Victorian Cancer Biobank (Peter MacCallum Cancer Centre Tissue Bank), Australia

Certification Status: Approved

Registration Status: Completed

Objective: The Peter MacCallum Cancer Centre Tissue Bank is a member of the Victorian Cancer Centre (VCB), a coordinated and integrated network of Biobanks located throughout the public and private health care system, collecting and distributing ethically obtained, high quality and highly annotated tissue and blood products to support cancer research in Australia and throughout the world with the aim of delivering better clinical outcomes to people with cancer. Since operations commenced in 2006, more than 50,000 Victorians undergoing cancer and other surgery have donated blood and tissue to VCB. The VCB has an open-door policy to public and private investigators or companies that have an ethically approved research project. VCB is customer focused with an enviable archival collection of over 600,000 bio-specimens in various storage formats, or we can support prospective collections.

Registered Biobank Name	Victorian Cancer Biobank (Peter MacCallum Cancer Centre Tissue Bank)
Biobank Leader	Samantha Cauberg
Country	Australia
Email for biobank inquiries	samantha.cauberg@petermac.org
Principal Investigator	Wayne Phillips
Website	https://viccancerbiobank.org.au
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).